Cardiovascular diseases are the leading cause of death throughout China. In an effort to reverse this trend, the ACC has a long history of working with partner societies and other stakeholders in China to optimize patient care and outcomes through targeted education and the sharing of research and best practices. Check out some of ACC's recent China-based efforts below.

• Hot Topics
  • Global Burden of CV Disease: East Asia (Webinar)
  • ACC.22: Registration, Key Dates and More
  • Save the Date: ACC Asia 2022 Together With KSC Spring Conference
  • COVID-19
    • COVID-19 Front Line Experience and Clinical Perspectives | China
    • Key Questions: COVID-19 and Cardiovascular Disease (Translated) 
• Clinician and Patient Tools
  • CardioSmart Patient Education (Chinese)
  • JACC: Asia
  • Additional Translated Resources
• Hypertension: New Perspectives on an Old Disease (Video Interview With Professor Huo Yong, MD, FACC)
• ACC Programs
  • NCD Academy
  • Global Heart Attack Treatment Initiative (GHATI)
  • ACC's China and U.S. Hospital Partnership Program (2020 Newsletters)

Be sure to follow ACC on WeChat for updates and resources.